Literature DB >> 8036796

A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion.

T Zeiler, G Wittmann, J Zingsem, V Weisbach, R Zimmermann, R Eckstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036796     DOI: 10.1111/j.1423-0410.1994.tb00318.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  5 in total

1.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

2.  Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.

Authors:  M Asfour; Aida Narvios; Benjamin Lichtiger
Journal:  MedGenMed       Date:  2004-07-13

3.  Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.

Authors:  Joan Cid; Miguel Lozano; Alyssa Ziman; Kamille A West; Kerry L O'Brien; Michael F Murphy; Silvano Wendel; Alejandro Vázquez; Xavier Ortín; Tor A Hervig; Meghan Delaney; Willy A Flegel; Mark H Yazer
Journal:  Br J Haematol       Date:  2014-10-04       Impact factor: 6.998

Review 4.  Anti-D Alloimmunization after RhD-Positive Platelet Transfusion in RhD-Negative Women under 55 Years Diagnosed with Acute Leukemia: Results of a Retrospective Study.

Authors:  Ana Villalba; Marta Santiago; Carmen Freiria; Pau Montesinos; Ines Gomez; Carolina Fuentes; Rebeca Rodriguez-Veiga; José María Fernandez; Guillermo Sanz; Miguel Angel Sanz; Nelly Carpio; Pilar Solves
Journal:  Transfus Med Hemother       Date:  2018-05-03       Impact factor: 3.747

5.  Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.

Authors:  Johanna Reckhaus; Markus Jutzi; Stefano Fontana; Vera Ulrike Bacher; Marco Vogt; Michael Daslakis; Behrouz Mansouri Taleghani
Journal:  Transfus Med Hemother       Date:  2018-05-24       Impact factor: 3.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.